Experience

Dr. Kishore Kumar Kota is a Medical and Hemato – Oncologist at Mahatma Gandhi Cancer Hospital & Research Institute, Visakhapatnam. He has over 6 yrs of experience in offering Specialized Oncology Care. 

• He worked as an Ad hoc Assistant professor, in Medical Oncology, TMH, Mumbai.
• He worked as an Ad hoc Assistant professor, of Medical Oncology, at HBCH & RC, Muzaffarpur.

Expertise

Area(s) of Interest

• Lung, Breast, Ovarian, Urological Malignancies
• Young and adolescent Malignancies: Germcell Tumors, Lymphomas, Gestational Trophoblastic Diseases
• Bone Marrow Transplant

Treatment(s)/ Procedure(s) Performed

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Palliative and Supportive Care
• Prevention and Screening of Cancer
• Solid Malignancies – Breast, Gynaecology, Gastroenterology, Thoracic, Urology, Head & Neck, Bone & Soft Tissue, CNS.
• Hematolymphoid Malignancies – ALL, AML, Lymphoma, CLL, CML, MPN, MDS

Treatment(s)/ Procedure(s) Offered

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Palliative and Supportive Care
• Prevention and Screening of Cancer
• Breast, Gynaecology, Gastroenterology, Thoracic, Urology, Head and Neck, and CNS Malignancies
• Young & Adolescent Malignancies
• Hematolymphoid Malignancies
• Bone Marrow Transplantation.

Doctor’s ScoreCard

The number of cases of  Medical & Hemato-Oncology Performed by Dr. Kishore Kumar Kota in the last 6+ years

Total: 2000

Education & Training

Name of Institute(s)

• DM (Medical Oncology), Tata Memorial Hospital, Mumbai.
• MD from Nizam Institute of Medical Sciences, Hyderabad.
• MBBS from Rangaraya Medical College, Kakinada.

Training

Trained at Bone Marrow Transplantation Unit, TMH Mumbai.

Professional Highlights

Publications

• Diclofenac versus tramadol for mucositis-related pain in Head and Neck Cancer Patients undergoing concurrent chemoradiation —a phase 3 study
• A randomized open-label phase III study evaluating olanzapine 2.5mg Vs 10mg plus standard triple antiemetic therapy for prevention of chemotherapy-induced nausea & vomiting in patients receiving highly emetogenic cisplatin-based chemotherapy in solid tumors: A phase III study  (Ongoing study)
• Evaluation of metronomic therapy in desmoid fibromatosis: Real-world data from a tertiary care center from a large developing country  (Ongoing study).
• Covid-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer: A questionnaire-based survey.

Professional Achievements & Membership

• Member of Andhra Pradesh Medical Council – Registration Number: 71731
• Registered Member of Maharashtra State Medical Council.
• Member of ISMPO 
• Member of ASCO 

Breakthrough Case(s) & Testimonial(s)

Breakthrough Case(s)

 1. Cutaneous T cell Lymphoma: Middle-Aged Female Achieved Complete Response after Chemotherapy.

2. Achieved Cure in a Major Number of Treated Germcell Tumors, Gestational Trophoblastic Tumors, Lymphomas.